Haematology in rats in 2-week toxicity study with oral ASD formulation: Parameters with flubendazole-induced changes (mean value ± standard deviation) (excluding satellite animals) on Day 15 (Vehicle, Low and Mid Dose Groups) or Day 7 or 8 (High Dose Groups).</p
<p>Comparative flubendazole (FLBZ) mean (± SD) plasma concentration profiles obtained after administ...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after 2 days of repeated oral dosin...
Background: Flubendazole, originally developed to treat infections with intestinal nematodes, has be...
Macroscopic findings in rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehicle, ...
Microscopic findings in male rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehi...
Microscopic findings in female rats in 2-week toxicity study with oral ASD formulation on Day 15 (Ve...
Organ weights (gram, mean value ± standard deviation) in rats in 2-week toxicity study with oral ASD...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ at Day 14 in satellite rats in 2-we...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after oral administration of ASD fo...
Clinical chemistry in dogs in 2-week toxicity study with oral ASD formulation: parameters with flube...
Microscopic findings in male dogs in 2-week toxicity study with oral ASD formulation end of treatmen...
Food consumption (gram/animal/day, mean value ± standard deviation) in rats in 2-week toxicity study...
Microscopic findings in female dogs in 2-week toxicity study with oral ASD formulation end of treatm...
Body weight gain (% difference in body weight compared to body weight on Day 1, mean value ± standar...
Plasma pharmacokinetic parameters after intravenous and oral administration of ASD formulation of fl...
<p>Comparative flubendazole (FLBZ) mean (± SD) plasma concentration profiles obtained after administ...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after 2 days of repeated oral dosin...
Background: Flubendazole, originally developed to treat infections with intestinal nematodes, has be...
Macroscopic findings in rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehicle, ...
Microscopic findings in male rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehi...
Microscopic findings in female rats in 2-week toxicity study with oral ASD formulation on Day 15 (Ve...
Organ weights (gram, mean value ± standard deviation) in rats in 2-week toxicity study with oral ASD...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ at Day 14 in satellite rats in 2-we...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after oral administration of ASD fo...
Clinical chemistry in dogs in 2-week toxicity study with oral ASD formulation: parameters with flube...
Microscopic findings in male dogs in 2-week toxicity study with oral ASD formulation end of treatmen...
Food consumption (gram/animal/day, mean value ± standard deviation) in rats in 2-week toxicity study...
Microscopic findings in female dogs in 2-week toxicity study with oral ASD formulation end of treatm...
Body weight gain (% difference in body weight compared to body weight on Day 1, mean value ± standar...
Plasma pharmacokinetic parameters after intravenous and oral administration of ASD formulation of fl...
<p>Comparative flubendazole (FLBZ) mean (± SD) plasma concentration profiles obtained after administ...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after 2 days of repeated oral dosin...
Background: Flubendazole, originally developed to treat infections with intestinal nematodes, has be...